Redwood AI Shares Jump 10% on US Access and Quantum Deal, Board Resignation Adds Uncertainty
Published on 06/16/2026 at 16:23 | Redaktion boerse-global.de
Redwood AI’s stock surged 10 percent to €1.98 on the Tradegate exchange Tuesday, driven by two strategic developments that have rekindled investor interest. The company secured Depository Trust Company (DTC) eligibility for its shares on the OTCQB Venture Market in the United States, clearing the way for electronic settlement and making the stock more accessible to North American investors. At the same time, management signed a non-binding letter of intent to acquire Quantum.IQ, a cybersecurity firm focused on protecting against quantum-computer-based attacks.
The gains stand in sharp contrast to the turmoil that hit the stock just days earlier. On Friday, board member Graydon Bensler resigned with immediate effect for undisclosed reasons, sending the shares to a low of C$2.90. That marked a loss of nearly 40 percent over the month and left the company far from its all-time high of more than C$10 set in April. A technical bounce on Monday lifted the stock by roughly 7 percent to C$3.10, but the recovery remains fragile.
The DTC approval, granted in late May, is Redwood AI’s latest push to broaden its shareholder base and improve liquidity. Listing on the OTCQB, a venture-market tier for U.S.-traded companies that do not meet the requirements of a national exchange, should make it easier for institutional and retail investors in North America to buy and sell the shares. The company is betting that greater accessibility will attract new long-term holders.
Should investors sell immediately? Or is it worth buying Redwood AI?
Parallel to the US market push, Redwood AI is deepening its bet on post-quantum cybersecurity. The proposed acquisition of Quantum.IQ would integrate the target’s encryption techniques with the company’s own artificial-intelligence software to create defenses against future quantum-computing threats. The deal is still subject to due diligence and regulatory approvals, but management has called it a concrete milestone in its dual strategy of focusing on AI-driven healthcare tools and quantum-safe security.
That healthcare pillar took another step forward with a preliminary agreement signed with the University of Global Health Equity in Rwanda. Redwood AI plans to build AI-powered early-detection systems for infectious diseases such as Ebola. However, the memorandum of understanding is non-binding and lacks a defined budget or committed financing, leaving market observers skeptical about the timeline for delivery. An earlier similar initiative in the region also remains at an early stage.
Away from the splashy deals, Redwood AI continues to advance its core platform. The company’s Reactosphere chemistry database now catalogs 21 million chemical reactions, and in early June it filed a US patent application for a new planning module. These building blocks are essential for the company to move from aspirational announcements to revenue-generating products.
With annualized volatility exceeding 130 percent and a market capitalization of roughly $116 million, Redwood AI remains a story of ambition rather than execution. The resignation of a board member, the uncommitted nature of its African and acquisition plans, and the stock’s extreme price swings underscore the challenge ahead. To rebuild trust, the company will need to convert its letters of intent into firm contracts that deliver measurable results.
Ad
Redwood AI Stock: New Analysis - 16 June
Fresh Redwood AI information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
